Another study in AA men revealed that, compared to cases with either alteration alone, prostate tumors with both CHD1 deletion and SPOP mutations showed significantly higher levels of HR deficiency-associated signatures and large-scale structural rearrangements (59). This evidence concerns the gene SPOP and prostate neoplasm.